Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-04-23 | New | $4,791,203 | $4,791,203 | Equity and Debt | 06b | SEC link |
| 2022-08-24 | New | $66,720 | $66,720 | Other | 06b | SEC link |
| 2021-12-10 | New | $33,760,493 | $33,760,493 | Equity Only | 06b | SEC link |
| 2021-01-28 | New | $22,446 | $22,446 | Other | 06b | SEC link |
| 2019-06-27 | New | $4,649,995 | $4,649,995 | Equity Only | 06b | SEC link |
| 2019-03-15 | Amended | $2,537,660 | $1,370,994 | Equity Only | 06b | SEC link |
| 2018-01-18 | New | $1,166,666 | $1,166,666 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Josko Bobanovic | Director |
| Doug Cameron | Director |
| Alastair Cooper | Director |
| Jim Flatt | Director, Executive |
| Carolyn Fritz | Director |
| Ashley Jenkins | Executive |
| K'lynne Johnson | Director |
| Matthew Lipscomb | Director |
| Michael D. Lynch | Director |
| Rob Van Der Meij | Director |
| Josh Yelen | Executive |